ArticleBMJ open2024

Phase I-IIa clinical trial to evaluate the safety, feasibility and efficacy of the use of a palate mucosa generated by tissue engineering for the treatment of children with cleft palate: the BIOCLEFT study protocol.

Antonio España-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.